Clinical Outcomes will be attending BioTrinity 2024

9th April 2024

Oxford University Innovation's Clinical Outcome team will be attending BioTrinity 2024 conference in London, UK on the 23-24th April 2024.

We are excited to be attending the BioTrinity 2024 conference in person.

BioTrinity is OBN’s flagship two-day conference for the life sciences industry, designed to catalyse growth for all who attend. The delegate mix comprises early stage and emerging life sciences R&D companies, investors, big pharma, academics, charities, government, and a broad range of valued service providers. The event will see Outcomes networking,hearing the latest and discussing industry trends, and exploring potential collaboration with other delegates.

Dr Liisa Chisty, Deputy Head of Group Licensing and Ventures – Life Sciences and Clinical Outcomes, will be available to meet you during the conference to discuss any aspect of our COA portfolio. You can reach the team via healthoutcomes@innovation.ox.ac.uk or look for OUI on the BioTrinity Partnering Programme to connect.

We look forward to seeing you there!

Press release sign up